Skip to main content
ROIV logo
ROIV
(NASDAQ)
Roivant Sciences Ltd.
$28.33-- (--)
Loading... - Market loading

Roivant Sciences (ROIV) Stock Price & Financial Analysis

Roivant Sciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$26.62 - $28.55
52-Week High$30.33
52-Week Low$8.73
Open$26.95
Volume5.01M
Average Volume (3M)5.01M
Market Cap19.74B
Shares Outstanding696.86M
Price to Sales (P/S)1457.59
Price to Book (P/B)4.54
EV/EBITDA-14.89
Revenue (TTM)13.31M
Net Income (TTM)-809.24M
Free Cash Flow (TTM)-766.86M
EPS (TTM)$-1.16
Profit Margin-6079.94%
Operating Margin-9130.53%
Return on Equity (ROE)-18.96%
Debt to Equity0.03
50-Day MA$26.51
200-Day MA$18.82
52-Week Change182.64%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Roivant Sciences

What is the current stock price for ROIV?

As of the latest trading session, ROIV stock trades at $28.33. The 52-week range is $8.73–$30.33, with a day range of $26.62–$28.55.

What is the P/E ratio for ROIV?

The P/E ratio (Price-to-Earnings) for ROIV is shown in the Key Statistics section. This valuation metric helps compare Roivant Sciences Ltd. to industry peers.

Does ROIV pay dividends?

Roivant Sciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ROIV?

Based on 3 analysts, the consensus for ROIV is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ROIV?

Roivant Sciences's market capitalization is $19.74B, classifying it as a large-cap company. Roivant Sciences operates in the Healthcare sector within the Biotechnology industry.